Radiopharmaceuticals: lutetium LU 177 pluvicto 27MCI/ML.
Ended Awarded Last action
- Contract number
- 36C26025N0127
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $232,604
Award facts
- Contract value 100% obligated
- $232,603.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Hanover, NJ 07936, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | -$760,669 | |
| Original award | $993,273 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary headquartered in Millburn, New Jersey, has been awarded a Blanket Purchase Agreement call valued at $232,603.98 for the supply of Lutetium Lu 177 Pluvicto 27 millicuries per milliliter, a specialized radiopharmaceutical used in targeted radioligand therapy for prostate cancer treatment. The contract, awarded January 1, 2025, with completion by December 31, 2025, is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) on a firm fixed-price basis by Veterans Integrated Service Network 20, part of the Department of Veterans Affairs. The product will be distributed from the contractor's East Hanover, New Jersey facility. This award carries no small business set-aside designation, consistent with Advanced Accelerator Applications USA Inc.'s status as an established large manufacturer and the specialized nature of radiopharmaceutical production.
This BPA call represents a delivery order against Advanced Accelerator Applications USA Inc.'s existing $6 million blanket purchase agreement with VISN 20 for Pluvicto supply extending through December 31, 2026. The contractor maintains an extensive portfolio of federal contracts across multiple Veterans Integrated Service Networks and other agencies, including the Defense Health Agency and National Institutes of Health, supplying advanced nuclear medicine products for both therapeutic and diagnostic applications. The firm has served as the primary federal supplier of radiopharmaceuticals since its registration in 2004, with no identified subcontractors on its contract awards, indicating direct prime contractor delivery of these critical healthcare products to the VA medical center system.
Quick answers
Who was awarded contract 36C26025N0127?
36C26025N0127 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 1, 2025.
How much is contract 36C26025N0127 worth?
The government has obligated $232,604 on 36C26025N0127.
Is contract 36C26025N0127 an order under another contract?
Yes. 36C26025N0127 is a BPA call under 36F79719D0169-36C26025A0008, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025N0127 competed?
The extent of competition for 36C26025N0127 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award